Millions of unapproved antibiotics are being sold in India each year, according to a new study published in the British Journal of Clinical Pharmacology. The study also revealed that multinational pharmaceutical companies continue to manufacture dozens of unapproved formulations, despite the global health crisis of rising antimicrobial resistance.
